Rene Claúdio Gansl

704 total citations
22 papers, 500 citations indexed

About

Rene Claúdio Gansl is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Rene Claúdio Gansl has authored 22 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Rene Claúdio Gansl's work include Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Rene Claúdio Gansl is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Rene Claúdio Gansl collaborates with scholars based in Brazil and United States. Rene Claúdio Gansl's co-authors include Wladimir Nadalin, Angelita Habr‐Gama, Joaquim Gama‐Rodrigues, Ulysses Ribeiro, Afonso Henrique Silva e Sousa, Fábio Guilherme Campos, Everardo D. Saad, Paulo M. Hoff, Sérgio D. Simon and Artur Katz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Rene Claúdio Gansl

20 papers receiving 488 citations

Peers

Rene Claúdio Gansl

ONCOL

SURGE

PRM

EPIDE

A Cheirsilpa Thailand

Jaime Arthur Pirola Krüger Brazil

Gilton Marques Fonseca Brazil

Hanlim Choi South Korea

Makoto Kadokura Japan

Yoshinori Takeda Japan

Hidetoshi Fukuoka Japan

Harunobu Sato Japan

Konrad Schoppmeyer Germany

Wenping Lu China

A Cheirsilpa Thailand

Rene Claúdio Gansl

252 ×0.6

ONCOL

367 ×1.4

SURGE

143 ×1.2

PRM

91 ×1.7

EPIDE

37 ×0.8

Citations per year, relative to Rene Claúdio Gansl Rene Claúdio Gansl (= 1×) peers A Cheirsilpa

Countries citing papers authored by Rene Claúdio Gansl

Since Specialization

Citations

This map shows the geographic impact of Rene Claúdio Gansl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rene Claúdio Gansl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rene Claúdio Gansl more than expected).

Fields of papers citing papers by Rene Claúdio Gansl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rene Claúdio Gansl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rene Claúdio Gansl. The network helps show where Rene Claúdio Gansl may publish in the future.

Co-authorship network of co-authors of Rene Claúdio Gansl

This figure shows the co-authorship network connecting the top 25 collaborators of Rene Claúdio Gansl. A scholar is included among the top collaborators of Rene Claúdio Gansl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rene Claúdio Gansl. Rene Claúdio Gansl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Usón, Pedro Luiz Serrano, et al.. (2020). BODY COMPOSITION IMPACT ON SURVIVAL AND TOXICITY OF TREATMENT IN PANCREATIC CANCER: CROSS-SECTIONAL PILOT STUDY. Arquivos de Gastroenterologia. 57(3). 278–282. 5 indexed citations

Nasser, Felipe, et al.. (2017). Liver Metastases in Pancreatic Acinar Cell Carcinoma Treated with Selective Internal Radiation Therapy with Y-90 Resin Microspheres. SHILAP Revista de lepidopterología. 2017. 1–7. 4 indexed citations

Eiger, Daniel, et al.. (2017). Sustained Viral Response to Ipilimumab Treatment in a Patient with HCV Chronic Infection and Metastatic Melanoma: A Case Report. Journal of Pharmacy and Pharmacology. 5(5). 1 indexed citations

Goldenberg, Alberto, et al.. (2015). Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered. Einstein (São Paulo). 13(3). 347–351. 8 indexed citations

Soares, Andrey, et al.. (2012). Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases. Case Reports in Oncology. 5(1). 104–109. 10 indexed citations

Hoff, Paulo M., Everardo D. Saad, Frederico Costa, et al.. (2011). Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer. 11(2). 93–100. 63 indexed citations

Saad, Everardo D., et al.. (2010). Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer. Revista da Associação Médica Brasileira. 56(1). 22–26. 2 indexed citations

Gansl, Rene Claúdio, et al.. (2008). Pretreatment level of CA 19–9 is a prognostic factor in advanced pancreatic cancer treated with chemotherapy. Journal of Clinical Oncology. 26(15_suppl). 15637–15637. 2 indexed citations

Smaletz, Òren, et al.. (2005). PSA decline does not correlate with overall survival in clinical trials with docetaxel for androgen independent prostate cancer (AIPC). Journal of Clinical Oncology. 23(16_suppl). 4673–4673. 1 indexed citations

10.

Katz, Artur, et al.. (2004). Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy. Journal of Clinical Oncology. 22(14_suppl). 1542–1542.

11.

Katz, Artur, et al.. (2004). Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy. Journal of Clinical Oncology. 22(14_suppl). 1542–1542. 5 indexed citations

12.

Saad, Everardo D., Marcel Cerqueira César Machado, Dalia Wajsbrot, et al.. (2002). Pretreatment CA 19-9 Level as a Prognostic Factor in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine. International Journal of Gastrointestinal Cancer. 32(1). 35–42. 81 indexed citations

13.

Saad, Everardo D., Paulo M. Hoff, Artur Katz, et al.. (2002). Critérios comuns de toxicidade do Instituto Nacional de Câncer dos Estados Unidos. SHILAP Revista de lepidopterología. 48(1). 63–96. 14 indexed citations

14.

Habr‐Gama, Angelita, Ulysses Ribeiro, Wladimir Nadalin, et al.. (1998). Low rectal cancer. Diseases of the Colon & Rectum. 41(9). 1087–1096. 234 indexed citations

15.

Habr‐Gama, Angelita, et al.. (1994). [Primary lymphomas of the large intestine].. PubMed. 48(6). 272–7. 1 indexed citations

16.

Katz, Artur, Rene Claúdio Gansl, Sérgio D. Simon, et al.. (1991). Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric Cancer. American Journal of Clinical Oncology. 14(4). 357–358. 10 indexed citations

17.

Feher, Olavo, et al.. (1991). Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis. Cancer. 68(8). 1821–1823. 18 indexed citations

18.

Habr‐Gama, Angelita, et al.. (1989). Epidermoid carcinoma of the anal canal. Diseases of the Colon & Rectum. 32(9). 773–777. 28 indexed citations

19.

Gansl, Rene Claúdio, et al.. (1989). [Treatment of cutaneous ulcerations caused by adriamycin extravasation].. PubMed. 106(4). 197–200.

20.

Gansl, Rene Claúdio, et al.. (1986). Treatment of liver metastatic colorectal carcinoma with sequential methotrexate (mtx), 5-fluorouracil (5-fu) and external hepatic radiation. Digestive Diseases and Sciences. 31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact